Nerve stimulator and method using simultaneous electrical and optical signals

ABSTRACT

An apparatus and method for stimulating animal tissue (for example to trigger a nerve action potential (NAP) signal in a human patient) by application of both electrical and optical signals for treatment and diagnosis purposes. The application of an electrical signal before or simultaneously to the application of a NAP-triggering optical signal allows the use of a lower amount of optical power or energy than would otherwise be needed if an optical signal alone was used for the same purpose and effectiveness. The application of the electrical signal may precondition the nerve tissue such that a lower-power optical signal can be used to trigger the desired NAP, which otherwise would take a higher-power optical signal were the electric signal not applied. Some embodiments include an implanted nerve interface having a plurality of closely spaced electrodes placed transversely and/or longitudinally to the nerve and a plurality of optical emitters.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority benefit under 35 U.S.C. §119(e) to U.S. Provisional Patent Application No. 61/102,811 filed on Oct. 3, 2008, titled “Nerve Stimulator and Method using Simultaneous Electrical and Optical Signals,” which is incorporated herein by reference in its entirety.

This is related to U.S. patent application Ser. No. 12/018,185, titled “Hybrid Optical-Electrical Probes,” filed Jan. 22, 2008 (which issued as U.S. Pat. No. 7,883,536 on Feb. 8, 2011), by some of the inventors of the present invention, which application is incorporated herein by reference in its entirety.

This invention is also related to prior:

-   U.S. patent application Ser. No. 11/257,793 filed Oct. 24, 2005     (which issued as U.S. Pat. No. 7,736,382 on Jun. 15, 2010), titled     “Apparatus and Method for Optical Stimulation of Nerves and Other     Animal Tissue”; -   U.S. patent application Ser. No. 11/536,639 filed Sep. 28, 2006     (which issued as U.S. Pat. No. 7,988,688 on Aug. 2, 2011), titled     “Miniature Apparatus and Method for Optical Stimulation of Nerves     and Other Animal Tissue”; -   U.S. patent application Ser. No. 11/536,642 filed Sep. 28, 2006,     titled “Apparatus and Method for Stimulation of Nerves and Automated     Control of Surgical Instruments”; -   U.S. Provisional Patent Application No. 60/872,930 filed Dec. 4,     2006, titled “Apparatus and Method for Characterizing Optical     Sources Used with Human and Animal Tissues”; -   U.S. patent application Ser. No. 11/948,912 filed Nov. 30, 2007,     titled “Apparatus and Method for Characterizing Optical Sources Used     with Human and Animal Tissues”; -   U.S. Provisional Patent Application No. 60/884,619 filed Jan. 11,     2007, titled “Vestibular Implant Using Infrared Nerve Stimulation”;     and -   U.S. patent application Ser. No. 11/971,874 filed Jan. 9, 2008     (which issued as U.S. Pat. No. 8,012,189 on Sep. 6, 2011), titled     “Method and Vestibular Implant Using Optical Stimulation of Nerves”;     each of which is incorporated herein by reference in its entirety.

FIELD OF THE INVENTION

The invention relates generally to tissue electro-optics (interactions of electricity and light with human or non-human animal tissue), and more particularly to methods, and both implantable and non-invasive apparatus for stimulating animal tissue in vivo, for example, stimulating and triggering a nerve action potential in nerves (e.g., nerves of the auditory or vestibular system in animals, and in particular, humans) utilizing both electrical-signal and optical-signal stimulation.

BACKGROUND OF THE INVENTION

As a convention used herein, a nerve will be defined as a collection of individual nerve fibers (i.e., axons) of individual nerve cells (neurons) that together form an integrated pathway within the nervous system. Subsets of the individual nerve fibers are each bundled into one of a plurality of fascicles that together form the nerve. Action potentials can occur in the axon portion of individual nerve cells. A series of individual nerve fibers that together form an integrated signal pathway starting at a sensory-receptor nerve ending and extending to the brain will be referred to as a sensory-nerve pathway, a series of individual nerve fibers that together form an integrated signal pathway starting at the brain and extending to a muscle cell will be referred to as a motor-nerve pathway. Within each fascicle of a nerve, there will typically be a plurality of sensory-nerve pathways and a plurality of motor-nerve pathways, wherein the number of sensory-nerve pathways will typically be about fifteen times as many as the number of motor-nerve pathways. As well, a series of individual nerve fibers may together form an integrated pathway starting at one of various internal organs and ending in the brain, with then other series of individual nerve fibers together forming an integrated pathway starting at the brain and extending to some internal end organ (such as the digestive tract, the heart, or blood vessels) as part of the autonomic nervous system; and a series of individual nerve fibers may together form an integrated pathway within the brain referred to as a tract. As used herein, a nerve bundle or fascicle refers to a collection of nerve fibers that subserve a like function (e.g., a fascicle may support a plurality of different motor-nerve pathways and thus motor-control signals needed for the muscles for a hand grasp, for example; similarly the same and/or a nearby fascicle may support a plurality of corresponding sensory-nerve pathways and thus sensory signals that provide the brain with feedback for the hand grasp).

FIG. 1A is a schematic diagram 101 of a nerve (adapted from www.mayoclinic.org/peripheral-nerve-tumors-benign/diagnosis.html). A nerve 11 contains fascicles (bundles) 12 of individual nerve fibers 13 of neurons. FIG. 1B is a schematic diagram 102 of the structure of a spinal nerve 11 that includes its surrounding epineurium 14, which includes connective tissue and blood vessels 15, one or more fascicles (fasciculus) 12, each of which is surrounded by perineurium 17. Within a fascicle 12 is a plurality of axons 13 each having a myelin sheath surrounded by endoneurium tissue 18 (credit to internet sources: en.wikipedia.org/wiki/Nerve_fascicle and trc.ucdavis.edu/mjguinan/apc100/modules/nervous/pns/nerve1/nerve1.html).

Typically a nerve action potential (NAP) or compound nerve action potential (CNAP), which is a summated potential of the action potentials in all the axons in a nerve, as a signal travels down a nerve, is sensed using an electrical sensor probe that detects the waveform of a voltage associated with the NAP. Accordingly, traditional methods used electrical stimulation to trigger a NAP signal in a nerve. One disadvantage of using electrical stimulation is that the electrical signal applied to stimulate one nerve fiber will generally stimulate a plurality of surrounding nerve fibers (even nerve fibers in other fascicles than the fascicle containing the nerve of interest) to also trigger NAP signals in those other nerve fibers: Present neuromodulation technology is based on the generation of electric fields around the neuron. The spatial differential voltage along the axons, commonly referred to as the driving function, results in a depolarization of the neural membrane. This depolarization results in action-potential generation, which is then transmitted to target organ where it produces a characteristic effect. The electric field is significantly influenced by the electrical impedance of the tissues.

Extraneural electrodes, such as the Flat Interface Nerve Electrode (FINE), have demonstrated fascicular selectivity (to within about 400 μm). The perineurium, which surrounds a plurality of nerve axons and defines the individual fascicle, typically has a high impedance. This causes the voltage distribution to be fairly uniform within at least a portion of a fascicle (while also being electrically isolated from neighboring fascicles), hence limiting the possibility of sub-fascicular selectivity when using electrical stimulation. While the spatial selectivity of these extraneural electrodes (such as the FINE) has been successfully shown to produce functional neural stimulation in clinical applications, neuromodulation applications such as hand-grasp, sensory-stimulation applications for artificial prostheses, and control of autonomic functions such as cardiac rate via Vagus-nerve stimulation, require, in some cases, selection of at most one fascicle and even greater sub-fascicular spatial selectivity (i.e., selection of a single axon or just a few axons but not all the axons in the single fascicle) than is typically possible using electrical stimulation alone, such that separate signals are delivered to different axons within one fascicle.

Prior Innovations To Increase Selectivity With Electrical Stimulation:

A number of innovative electrode designs have advanced spatial selectivity for stimulation of nerve fascicles. The spiral electrode, introduced in 1988 (Naples, G. G., J. T. Mortimer, et al., (1988), “A spiral nerve cuff electrode for peripheral nerve stimulation,” IEEE Trans Biomed Eng 35(11): 905-16), has been shown in animal models to cause negligible changes in nerve morphology (Grill, W. M. and J. T. Mortimer (1998), “Stability of the input-output properties of chronically implanted multiple contact nerve cuff stimulating electrodes,” IEEE Trans Rehabil Eng 6(4): 364-73; Grill, W. M. and J. T. Mortimer (2000), “Neural and connective tissue response to long-term implantation of multiple contact nerve cuff electrodes,” J Biomed Mater Res 50(2): 215-26) and was capable of selective stimulation (Sweeney, J. D., D. A. Ksienski, et al., (1990), “A nerve cuff technique for selective excitation of peripheral nerve trunk regions.” IEEE Trans Biomed Eng 37(7): 706-15; Sweeney, J. D., N. R. Crawford, et al., (1995)., “Neuromuscular stimulation selectivity of multiple-contact nerve cuff electrode arrays,” Med Biol Eng Comput 33(3 Spec No): 418-25; Tarler, M. D. and J. T. Mortimer, (2003), “Comparison of joint torque evoked with monopolar and tripolar-cuff electrodes,” IEEE Trans Neural Syst Rehabil Eng 11(3): 227-35). Twenty-one spiral electrodes have been implanted in five human subjects for periods between three months and three years without any observable loss of neural function that would be indicative of chronic damage. These electrodes have demonstrated moderate selectivity sufficient for neuromodulation in the upper and lower extremities. More refined applications require greater selectivity than currently achieved with the spiral electrode.

The Flat Interface Nerve Electrode (FINE), introduced in 2002 (Tyler, D. J. and D. M. Durand, (2002), “Functionally selective peripheral nerve stimulation with a flat interface nerve electrode,” IEEE Trans Neural Syst Rehabil Eng 10(4): 294-303; also described in U.S. Pat. No. 6,456,866 issued to Tyler et al., discussed below), has been shown in animal models to attain a high level of fascicular stimulation and recording selectivity with negligible changes in nerve morphology (Tyler and Durand 2002 ibid.; Leventhal, D. K. and D. M. Durand, (2004), “Chronic measurement of the stimulation selectivity of the flat interface nerve electrode,” IEEE Trans Biomed Eng 51(9): 1649-58; Tyler, D. J. and D. M. Durand, (2003), “Chronic response of the rat sciatic nerve to the flat interface nerve electrode,” Ann Biomed Eng 31(6): 633-42; Yoo, P. B. and D. M. Durand, (2005), “Selective recording of the canine hypoglossal nerve using a multicontact flat interface nerve electrode,” IEEE Trans Biomed Eng 52(8): 1461-9). Studies involving computational modeling have shown that the FINE electrode can selectively activate individual muscles within the femoral nerve stimulation (Schiefer, M. A., R. J. Triolo, et al., (2008), “A Model of Selective Activation of the Femoral Nerve with a Flat Interface Nerve Electrode for a Lower Extremity Neuroprosthesis,” IEEE Trans Neural Syst Rehabil Eng). The femoral nerve is composed of up to forty-three (43) fascicles in the dog or cat model, with several fascicles innervating each muscle. Electrical stimulation with the spiral and FINE electrode designs can be effective, but these electrode designs are limited in their ability to stimulate each of the forty-three (43) fascicles individually. Anatomic studies of the human upper extremity nerves show that these nerves have a large number of fascicles. Higher-precision spatial selectivity of individual nerve fascicles would enable more refined function to neuromodulation therapies, many of which still have ample opportunity for improved control of function.

To further increase fascicle and subfascicular selectivity, intrafascicular electrodes place stimulation electrodes within the individual nerve fascicles. Intraneural electrode arrays, such as the Utah Slanted Electrode Array (USEA) (see Branner, A. and R. A. Normann, (2000), “A multielectrode array for intrafascicular recording and stimulation in sciatic nerve of cats,” Brain Res Bull 51(4): 293-306) and polymer longitudinal intrafascicular electrode (polyLIFE) (see Malmstrom, J. A., T. G. McNaughton, et al., (1998), “Recording properties and biocompatibility of chronically implanted polymer-based intrafascicular electrodes,” Ann Biomed Eng 26(6): 1055-64), penetrate through the perineurium to place contacts within the fascicles, in direct contact with axons. This has been demonstrated to be effective for selective stimulation, although there is evidence that this approach may cause damage to the nerve. Violation of the perineurium typically compromises the blood-nerve-barrier and other protective mechanisms of the perineurium. Owing to the simplicity and proven chronic experience of the circumneural approaches, an alternative method of stimulation that can improve the fascicular and subfascicular selectivity beyond the FINE would be a significant alternative to intrafascicular stimulation.

An emerging technology that significantly increases the spatial precision of nerve stimulation uses pulsed infrared light to reliably elicit neural action potentials in a non-contact manner (Wells, J. D., Kao, C., Jansen, E. D., Konrad, P., Mahadevan-Jansen, A., “Application of Infrared Light for in vivo Neural Stimulation,” Journal of Biomedical Optics, 2005; Wells, J. D., Kao, C., Mariappan, K., Albea, J., Jansen, E. D., Konrad, P., Mahadevan-Jansen, A., “Optical Stimulation of Neural Tissue in vivo,” Optics Letters, 2005. 30(5): p. 504-507, (collectively hereinafter “Wells et al. 2005”)). Infrared nerve stimulation (IRNS) was a result of an amalgamation of the fields of biomedical optics and neuroscience at Vanderbilt University. A systematic wavelength study using Vanderbilt University's tunable free-electron laser (2-10 μm) revealed that while most infrared wavelengths are capable of IRNS, 2.1 μm and 4 μm demonstrate the highest safety ratio for stimulation (safety ratio=laser radiant exposure required for thermal damage/laser radiant exposure required for stimulation resulting in a visible muscle twitch when stimulating the rat sciatic nerve). It was shown that IRNS using optimized laser parameters has a set of fundamental advantages over electrical stimulation that include high spatial selectivity, the ability to generate action potentials free of electrical stimulus artifact, non-contact stimulus delivery (even through bone), and MRI compatibility (Wells et al. 2005). These benefits make IRNS particularly attractive for clinical applications requiring precise, localized stimulation, such as use with diagnostic tools, neuroprostheses, and neurocognitive therapeutic devices.

Small, spatially localized neuronal populations have been stimulated with laser energy, which differs from the larger neuron populations that are stimulated by contemporary neural interfaces that use electrical current (Wells et al. 2005; Wells, J. D., Kao, Konrad, P., Mahadevan-Jansen, A., and Jansen, E. D., (2006), “Biophysical mechanisms responsible for pulsed low-level laser excitation of neural tissue,” Proc. SPIE 6084, 60840X (2006), DOI:10.1117/12.655239 (hereinafter “Wells et al. 2006”). Although important advances in spatial selectivity have been made in electrical stimulation (described above), the precision of electrical-stimulation techniques is fundamentally limited by the fact that electrical current spreads in a conductive medium (e.g., within a fascicle, since the tissue providing primary electrical insulation to prevent loss is the perineurium that surrounds the fascicle at its perimeter). A laser, on the other hand, offers a spatially restricted distribution of light that is predictable by the diffraction-limited spot size in the lateral direction, and a combination of the laser wavelength and the optical properties of the target tissue in the axial direction. This can have profound implications when applied to neuroprostheses. FIG. 2A and FIG. 2B illustrate the capability of optical stimulation to selectively activate specific fascicles within the main rat sciatic nerve to target specific muscle groups such as the gastrocnemius, while yielding no response from adjacent fibers that innervate the biceps femoris. Selective recruitment of nerve fibers is indicated by comparing the relative magnitudes of nerve and muscle potentials (FIG. 2A and FIG. 2B) elicited from optical and electrical stimulation. (Specifically, FIG. 2A and FIG. 2B show spatial targeting of IRNS. FIG. 2A shows threshold compound muscle action potential (CMAP) response from electrical stimulation of the main branch of the sciatic nerve proximal to the first branch point with 1.02 A/cm². FIG. 2B shows corresponding results from threshold optical stimulation (0.4 J/cm²) of specific target nerve fibers that innervate the gastrocnemius, with no response from adjacent nerve fibers (quiet biceps femoris). The distance from the stimulation spot to recording electrodes was held constant for trials involving each modality (optical IRNS, electrical, or both) (as shown in these graphs, these signals were amplified with a gain=1000).) Results from these studies demonstrate subfascicular selectivity using infrared nerve stimulation (IRNS), thus providing motivation for applying this technique to neuroprostheses with the vision of greater selectivity and improved clinical outcomes in restoration of function.

Thus, recently, very specific optical-stimulation waveforms and wavelengths have been used to stimulate a nerve to trigger a NAP signal. Delivering such optical energy using optical fibers has the advantages of the very small structures of the optical fiber and the very small target areas to which the optical signal can be confined, which provides a medical practitioner the ability to stimulate one or only a few nerve fascicles within a nerve bundle without triggering NAPs in neighboring fascicles to which the medical practitioner does not wish to deliver triggering stimulation. Typically, a relatively high fluence of optical energy is required to trigger a NAP. In some embodiments, the present invention provides ability to stimulate spots that are much smaller than the fascicle and thus trigger NAPs on a subfascicular basis.

While research data suggest that infrared-nerve-stimulation (IRNS) technology has distinct advantages over other standard stimulation methods, there are a number of engineering challenges and obstacles that must be overcome before this technology matures to the point of clinical utility. A comprehensive set of survival studies to identify upper limits for safe laser intensities in the mammalian peripheral nerve have been undertaken. A low-frequency, short-duration stimulation protocol (2 Hz, 20 pulses) was applied to 50 nerves using a broad range of radiant exposures above stimulation threshold (0.4-1.4 J/cm²) with the research-grade Capella R-1850 infrared nerve stimulator (available from Lockheed Martin Aculight Corporation, 22121 20th Avenue S.E., Bothell, Wash. 98021), which provides improved nerve selectivity, no electrical artifact, and non-contact operation. Upper limits for radiant exposure to stimulate the rat sciatic nerve without thermal injury were evaluated using histology both 3-5 days (n=34) and 14 days (n=16) following stimulation, for assessment of any delayed neuropathology (such as Wallerian degeneration) in the stimulated nerves. An expert pathologist specializing in laser-tissue interactions reported any sign of epineurial or axonal damage as a 1, while if there were no detected signs of damage, this was reported as a 0 (zero). Statistical analyses (obtained using a software program (Probit v2.1.2, Litton TASC, San Antonio, Tex., 1998) for analyzing yes/no data on a log scale was applied to the data collected from survival experiments. Results from histological analysis (yes=damage, no=no damage) were input into the software program such that the output yielded the probability of damage as a function of laser radiant exposure. The 50% probability of damage was also determined in these computations) are summarized in graph 300 in FIG. 3, where the probability of damage is graphed as a function of radiant exposure for 3-to-5-day, and two-week survival experiments. (Specifically, FIG. 3 shows probability of damage as a function of laser radiant exposure compared to the stimulation threshold. Results from statistical analysis show the probability of histological nerve damage versus the laser radiant exposure from data collected from 3-to-5-day survival studies (crosses, n=34) and 14-day survival studies (triangles, n=16). The results from studies to determine the range of threshold radiant exposures needed for stimulation are shown for comparison with 95% confidence intervals. This graph illustrates that a safe margin exists between the maximum laser radiant exposures required to stimulate and the minimum radiant exposures necessary for damage (P(damage)=0%). These results quantify the upper limits for brief, low-repetition-rate optical stimulation of the rat sciatic nerve.)

The stimulation threshold (e.g., in some embodiments, this is the level of stimulation that achieves a 0.5 probability for stimulation—a response occurring upon 50% of stimulation occasions) in the rat sciatic nerve was shown to be 0.41+/−0.07 J/cm² over a large number of trials (n=32). The radiant exposure with a 0.5 probability of thermal damage (damage occurring on 50% of occasions after a 2-Hz-and-20-pulses protocol as described in the previous paragraph) is 0.90 J/cm² in the 3-5-day survival studies and 0.95 J/cm² from two-week survivors. In some experiments, a fluence of less than 0.70 J/cm² resulted in no thermal damage. While these data suggest that a small, but clearly defined “safe zone” exists when using a low-frequency, short-duration stimulation protocol, the approximately two-times (˜2×) safety margin may need to be improved before clinical implementation of this technique. In contrast, the safety margin for damage to stimulation thresholds in electrical stimulation is greater than fifty times (50×) in most peripheral nerves.

Other experiments report the upper limit for safe laser-stimulation repetition rate occurs near 5 Hz and that the maximum duration for constant low-repetition-rate stimulation (2 Hz) is about 4 minutes with adequate tissue hydration (Wells et al. 2005). It should be pointed out that the scenario above is specific to stimulation of the rat sciatic nerve (a peripheral nerve) and eliciting a visible motor twitch in the down-stream muscles. In other work, stimulation thresholds that are nearly two orders of magnitude lower have been reported while stimulating the spiral ganglion cells in the gerbil cochlea (Izzo, Richter et al., “Laser Stimulation of the Auditory Nerve,” Lasers in Surgery and Medicine, Wiley-Liss, Inc, 2006; Izzo, Suh et al., “Selectivity of neural stimulation in the auditory system: an comparison of optic and electric stimuli,” Journal of Biomedical Optics, 12(2), 021008 (March/April 2007); Izzo, Walsh et al., “Optical Parameter Variability In Laser Stimulation: a study of pulse duration, repetition rate, and wavelength”, IEEE Trans. Biomed. Eng., 2007 June; 54(6 Pt 1):1108-14). In those experiments it was also shown that continuous stimulation at 300 Hz for up to six hours did not result in reduction in CNAP signals from the stimulated cells. Another experiment on gerbil nerves was reported by Teudt et al. who exposed the gerbil facial nerve to 250-microsecond pulses of 2.12-micron-wavelength radiation from a Ho:YAG laser via a 600-micron-diameter optical fiber at a repetition rate of 2 Hz with radiant exposures of between 0.71 J/cm² and 1.77 J/cm² to trigger compound muscle action potentials (CmAPs) (Teudt et al., “Optical Stimulation of the Facial Nerve: A New Monitoring Technique?”, The Laryngoscope VOL:117(9); p. 1641-7/200709/, Lippencott Williams and Wilkins, 2007). Histology by Teudt et al. 2007 revealed tissue damage at radiant exposures of 2.2 J/cm², but no apparent damage at radiant exposures of 2.0 J/cm².

Increases in nerve-tissue temperature during laser stimulation may result in nerve-tissue damage. FIGS. 4A-4D show graphs of steady-state maximum temperature increase in nerve tissue from Ho:YAG laser stimulation. (Graph 401 of FIG. 4A: Temperature rise from 0.45 J/cm² radiant exposure pulses at 2-Hz stimulation frequency. Graph 402 of FIG. 4B: Temperature rise from 0.65 J/cm² radiant exposures at 2-Hz stimulation frequency. Graph 403 of FIG. 4C: Temperature rise from 0.41 J/cm² threshold radiant exposures at 5-Hz stimulation frequency. Graph 404 of FIG. 4D: Temperature rise from 0.63 J/cm² threshold radiant exposures at 5-Hz stimulation frequency.) The resultant heat load in tissue (measured via IR thermography) during low-frequency stimulation (graph 401 of FIG. 4A) has adequate time to diffuse out of the irradiated zone via conduction and other heat-transfer mechanisms. However, as indicated in graph 403 of FIG. 4C and graph 404 of FIG. 4D showing higher-frequency stimulation, temperature superposition will begin to occur at repetition rates greater than about 4 to 5 Hz, as the tissue requires slightly greater than 200 msec to return to baseline temperature, since the thermal diffusion-time constant is ˜90 ms under these conditions. At repetition rates greater than 5 Hz tissue-temperature changes will become additive with each ensuing laser pulse, and resulting tissue damage may begin to occur with prolonged constant stimulation. These data also indicate that amount of temperature rise and the time to reach a steady-state temperature are dependent on the radiant exposure level. At lower radiant exposures the rise in temperature is smaller and reaches a steady-state temperature in a shorter time. What is needed is a means to reduce the radiant exposure levels required for reliable IRNS, which would greatly reduce the heat load (thus reducing the potential for tissue damage) and significantly advance the implementation of IRNS technology in highly precise neurostimulation devices.

U.S. Pat. No. 7,225,028 issued to Della Santina et al. on May 29, 2007, and titled “Dual Cochlear/Vestibular Stimulator with Control Signals Derived from Motion and Speech Signals,” is incorporated herein by reference. Della Santina et al. describe a system for treating patients affected both by hearing loss and by balance disorders related to vestibular hypofunction and/or malfunction, which includes sensors of sound and head movement, processing circuitry, a power source, and an implantable electrical stimulator capable of stimulating areas of the cochlea and areas of the vestibular system.

U.S. Patent Application Publication No. US 2007/0261127 A1 filed Jul. 24, 2006 by Edward S. Boyden and Karl Deisseroth, titled “LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF”; U.S. Patent Application Publication No. US 2007/0054319 A1 filed Jul. 24, 2006 by Edward S. Boyden and Karl Deisseroth, titled “LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF”; and U.S. Patent Application Publication No. US 2007/0053996 A1 filed Jul. 24, 2006 by Edward S. Boyden and Karl Deisseroth, titled “LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF,” are all incorporated herein by reference. These describe compositions and methods for light-activated cation channel proteins and their uses within cell membranes and subcellular regions. They describe proteins, nucleic acids, vectors and methods for genetically targeted expression of light-activated cation channels to specific cells or defined cell populations. In particular the description provides millisecond-timescale temporal control of cation channels using moderate light intensities in cells, cell lines, transgenic animals, and humans. The optically generated electrical spikes in nerve cells and other excitable cells are useful for driving neuronal networks, drug screening, and therapy.

U.S. Pat. No. 6,456,866, which issued to Tyler et al. on Sep. 24, 2002, titled “Flat interface nerve electrode and a method for use,” is incorporated herein by reference. Tyler et al. describe a flat interface nerve electrode (FINE) and a method for its use. The electrode provides a plurality of conductive elements embedded in a non-conductive cuff structure, which acts to gently and non-evasively redefine the geometry of a nerve through the application of a force so as to apply pressure to a nerve in a defined range. The cuff has an opening, which is elongated relative to the diameter of the nerve to which it is applied. Preferably, the cuff is constructed from an elastic bio-compatible material having top and bottom beam members configured to define a nerve opening. The cuff is open at one side and has a connection at the other side which results in a spring force being applied through the surfaces of the nerve opening to the subject nerve. During implantation the open sides of the cuff are closed so as to capture the nerve in the cuff. As the nerve is reshaped, specific nerve axons become more easily addressed through the epineurium by the embedded conductive elements.

U.S. Pat. No. 6,748,275, which issued to Lattner et al. on Jun. 8, 2004, and titled “Vestibular Stimulation System and Method,” is incorporated herein by reference. Lattner et al. describe an apparatus and method in which the portions of the labyrinth associated with the labyrinthine sense and/or the nerves associated therewith are stimulated to perform at least one of the following functions: augment or control a patient's respiratory function, open the patient's airway, induce sleep, and/or counteract vertigo.

U.S. Pat. No. 7,004,645, which issued to Lemoff et al. on Feb. 28, 2006, and titled “VCSEL array configuration for a parallel WDM transmitter,” is incorporated herein by reference. Lemoff et al. describe VCSEL array configurations. WDM is wavelength-division multiplexing. Transmitters that use several wavelengths of VCSELs are built up out of multiple die (e.g., ones having two-dimensional single-wavelength monolithic VCSEL arrays) to avoid the difficulty of manufacturing monolithic arrays of VCSELs with different optical wavelengths. VCSEL configurations are laid out to insure that VCSELs of different wavelengths that destined for the same waveguide are close together.

U.S. Pat. No. 7,116,886, which issued to Colgan et al. on Oct. 3, 2006, and titled “Devices and methods for side-coupling optical fibers to optoelectronic components,” is incorporated herein by reference. Colgan et al. describe optical devices and methods for mounting optical fibers and for side-coupling light between optical fibers and VCSEL arrays using a modified silicon V-groove, or silicon V-groove array, wherein V-grooves, which are designed for precisely aligning/spacing optical fibers, are “recessed” below the surface of the silicon. Optical fibers can be recessed below the surface of the silicon substrate such that a precisely controlled portion of the cladding layer extending above the silicon surface can be removed (lapped). With the cladding layer removed, the separation between the fiber core(s) and optoelectronic device(s) can be reduced resulting in improved optical coupling when the optical fiber silicon array is connected to, e.g., a VCSEL array.

U.S. Pat. No. 7,031,363, which issued to Biard et al. on Apr. 18, 2006, and titled “Long wavelength VCSEL device processing,” is incorporated herein by reference. Biard et al. describe a process for making a laser structure such as a vertical-cavity surface-emitting laser (VCSEL). The VCSEL designs described include those applicable to the 1200 to 1800 nm wavelength range.

U.S. Pat. No. 6,546,291, which issued to Merfeld et al. on Apr. 8, 2003, titled “Balance Prosthesis,” is incorporated herein by reference. Merfeld et al. describe a wearable balance prosthesis that provides information indicative of a wearer's spatial orientation. The balance prosthesis includes a motion-sensing system to be worn by the wearer and a signal processor in communication with the motion-sensing system. The signal processor provides an orientation signal to an encoder. The encoder generates a feedback signal on the basis of the estimate of the spatial orientation provides that signal to a stimulator coupled to the wearer's nervous system.

U.S. Pat. No. 6,171,239, which issued to Humphrey on Jan. 9, 2001 titled “Systems, methods, and devices for controlling external devices by signals derived directly from the nervous system,” is incorporated herein by reference. Humphrey describes a system to control prostheses and other devices with signals received by sensors implanted directly in the brain or other parts of the nervous system of a subject/patient and transmitted to an external receiver. The system has sensors in the form of bundles of small, insulated, flexible wires, configured in a parallel or twisted array, which are used to receive multicellular signals from small clusters of neurons. A new “calibration/adaptation” system is developed, in which the neural signals are cross-correlated with the parameters of a set of standardized or model movements as the subject/patient attempts to emulate the model movements, and on the basis of the correlations the neural signals that are best suited for control of the corresponding movement or movement parameter of the external device are selected. Periodic use of this calibration system compensates for or adapts to uncontrolled changes in neural signal parameters over time, and therefore results in re-selection of the optimal neural channels for better device control. Artificial neural nets are used for mapping the selected neural signals onto appropriate movements or control parameters of the external device.

Effective, specific and precise stimulation of selected nerves remains a problem. Improved apparatus and methods are needed to diagnose and/or treat various problems in animals (including humans).

SUMMARY OF THE INVENTION

The present invention provides apparatus and methods some or all of which may be combined in various embodiments for stimulating animal tissue (for example to trigger a nerve action potential signal in nerves of a human patient) by application of both electrical and optical signals for treatment and diagnosis purposes. In some embodiments, the application of an electrical signal before or simultaneously (or, in some embodiments, after) the application of an optical signal allows the use of a lower amount of optical power or energy than would otherwise be needed if an optical signal alone were used for the same purpose and effectiveness. The application of the electrical signal may precondition the nerve tissue (electrically “priming” the excitable tissue making it more susceptible to stimulation and in particular optical stimulation (sodium and potassium channels are voltage sensitive, such that the probability of a channel opening or being open increases with increased voltage differential from the outside to inside of the cell; upon channel opening, positively charged ions (sodium) move from the extracellular to intracellular space, thus affecting the probability of open for neighboring channels; in some embodiments, the present invention adjusts the voltage increase the probability that a channel is open)) such that a lower-power optical signal can be used to trigger the desired NAP with substantially the same selectivity as seen with the stand-alone optical stimulation that otherwise would take a higher-power optical signal, were the electric signal not applied. In some embodiments, the hybrid combination of electrical and optical stimulation overcomes limitations of each modality, significantly reducing IRNS-threshold levels (order of magnitude) while retaining the highly precise stimulation of discrete axonal populations, thus achieving high spatial selectivity for nerve stimulation with clinically viable safety and efficacy thresholds. This also reduces the optical power requirements for laser devices that mediate the stimulation of neural tissues, thus making implantable laser-based neuroprostheses and neurostimulators more practical for human use or allows more channels using the same power budget (i.e., the power budget being, e.g., the amount of power used in an implantable device).

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A is a schematic diagram 101 of a nerve 11.

FIG. 1B is a schematic diagram 102 of a nerve 11.

FIG. 2A includes a diagram 201 and graphs 211 and 221 showing different spatial specificities in the sciatic nerve when using electrical nerve stimulation.

FIG. 2B includes a diagram 202 and graphs 212 and 222 showing different spatial specificities in the sciatic nerve, of electrical nerve stimulation and optical nerve stimulation.

FIG. 3 is a graph 300 of the probability of damage in the rat sciatic nerve as a function of optical radiant exposure (J/cm²).

FIG. 4A is a graph 401 of steady-state maximum temperature increase in nerve tissue from pulsed Ho:YAG laser stimulation.

FIG. 4B is a graph 402 of steady-state maximum temperature increase in nerve tissue from pulsed Ho:YAG laser stimulation.

FIG. 4C is a graph 403 of steady-state maximum temperature increase in nerve tissue from pulsed Ho:YAG laser stimulation.

FIG. 4D is a graph 404 of steady-state maximum temperature increase in nerve tissue from pulsed Ho:YAG laser stimulation.

FIG. 5 is a perspective view, partially in cross section, of a system 500 having a hybrid-electrical-and-optical probe 520 developed to test for nerve stimulation thresholds according to some embodiments of the invention.

FIG. 6A is a schematic prior-art graph 610 of an electrical-only pulse set for nerve stimulation according to some embodiments of the prior art.

FIG. 6B is a schematic graph 620 of a hybrid-electrical-and-optical pulse set for nerve stimulation according to some embodiments of the invention.

FIG. 7A is a perspective schematic view and block diagram of a hybrid-electrical-and-optical system 700 for highly selective nerve stimulation according to some embodiments of the invention.

FIG. 7B is an enlarged perspective schematic view and block diagram of a portion of the hybrid-electrical-and-optical system 700 of FIG. 7A.

FIG. 7C is a perspective schematic view and block diagram of a hybrid-electrical-and-optical system 703 having one or more embedded electronic and/or optical chips according to some embodiments of the invention.

FIG. 8 is a perspective schematic view and block diagram of a hybrid-electrical-and-optical system 800 for nerve stimulation according to some embodiments of the invention.

FIG. 9 is a perspective view and block diagram of a hybrid-electrical-and-optical system 900 for nerve stimulation according to some embodiments of the invention.

FIG. 10A is a system schematic of the electrical optical hybrid stimulator 1001 according to some embodiments of the invention.

FIG. 10B is a system schematic of the electrical optical hybrid stimulator and prosthesis system 1002 according to some embodiments of the invention.

DETAILED DESCRIPTION OF THE INVENTION

Although the following detailed description contains many specifics for the purpose of illustration, a person of ordinary skill in the art will appreciate that many variations and alterations to the following details are within the scope of the invention. Accordingly, the following preferred embodiments of the invention are set forth without any loss of generality to, and without imposing limitations upon the claimed invention. Further, in the following detailed description of the preferred embodiments, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration specific embodiments in which the invention may be practiced. It is understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the present invention.

The leading digit(s) of reference numbers appearing in the Figures generally corresponds to the Figure number in which that component is first introduced, such that the same reference number is used throughout to refer to an identical component which appears in multiple Figures. Signals and connections may be referred to by the same reference number or label, and the actual meaning will be clear from its use in the context of the description.

FIG. 5 is a perspective view of a system 500 having a hybrid-electrical-and-optical probe 520 developed to test for nerve-stimulation thresholds according to some embodiments of the invention. In some embodiments, such as shown in FIG. 5, the electrical-optical (EO) probe 520 uses a metal tube 524 (or other suitable electrical conductor) with an optical fiber 521 and its fiber optic end 531 located within the tube (e.g., in some embodiments, the optical fiber is located in an axial direction in the center of the tube). In some embodiments, the metal tube 524 is made from a biocompatible material such as, for example, titanium or stainless steel or other compatible metals or other electrical conductors. In some embodiments, the fiber optic end 531 of optical fiber 521 is stripped to just the cladding and is bonded in to the center of the tube 524. In some embodiments, the range in fiber-core diameters used for the optical stimulator is from 200 μm to 600 μm (microns), with the fiber cladding, in some embodiments, being about 10% larger than the core. In some embodiments, the inner diameter of the tube is designed to accommodate the 660 μm (the core-plus-cladding diameter of an optical fiber 521 that has a 600-μm-diameter core) which would be the largest of the fiber cladding diameters for such fibers, in some embodiments. In some embodiments, the tip 531 of the fiber optic 521 is recessed within the tube 524 in order to provide a consistent distance between the fiber and the nerve 97 (see FIG. 8) that is to be stimulated. In some embodiments, conductor 524 includes metal that is plated or sputtered onto optical fiber 521 and then the tip 531 of optical fiber 521 is selectively etched away in order to recess the tip within conductor 524. In some embodiments, an external non-electrically conductive insulator 525, such as silicone (or other suitable polymer, ceramic, glass or other electrical insulator), is applied to the outside of the metal electrode 524 (e.g., acting as a handle and/or limiting the location and amount of conductor 524 that is exposed to the tissue of the patient) to allow for the user to place the probe 520 on the nerve 97 or nerve bundle 98 (see FIG. 8) without interfering with the delivery of the electrical stimulation. In some embodiments, an electrical-ground wire 528 and electrically conductive electrode 529 are provided (wherein, in some embodiments, electrode 529 is placed on the patient) in order to provide a ground reference for the electrical signal applied to electrical-conductor tip 524.

As an alternative or in addition to the combined probe 520 that is shown, other embodiments use two or more independent probes, including one probe that is an electrical probe held or placed on the patient's tissue near the nerve-stimulation/activation site, and another probe that is just an optical-fiber probe that is held or placed on or near nerve at the activation site. These separate electrical and optical probes are placed and/or held independently and thus provide to the user additional flexibility in where and how the probes are placed at various distances from each other and from the nerve-stimulation site. In some embodiments, these implementations are used to determine optimal or improved probe configurations and spacing parameters to use for fabricating hybrid probes that are manufactured to implement the optical spacing parameters but could potentially be applied in clinical settings as well. In some embodiments, the hybrid probe is configured such that the spacing or placement of the optical fiber delivery end relative to the electrode is adjustable by the medical professional who is operating the hybrid probe, in order to be able to manipulate, adjust, optimize and set the relative spacing and/or directions that the ends are pointing (e.g., the relative pitch and yaw of the vectors defining the relationship of the respective ends).

In some embodiments, in order to demonstrate lower infrared stimulation thresholds with combined electrical and optical stimulation, an integrated electrical and optical (EO) stimulation system is assembled. A useful feature for the EO system is a combined electrical and optical probe 520. In some embodiments, the design for the electrode includes a mono-polar conductive tube 524. In other embodiments, multi-polar electrode is used, and it includes additional wires or other conductor structures attached to the electrode. In some embodiments, the optical fiber 531 used to deliver infrared stimulation light is connected to and passes through the tube electrode 520 such that its end 521 is slightly recessed within the end of metal tube 524, as shown in FIG. 5. In some embodiments, a silicone coat or handle 525 is applied (and/or molded or otherwise applied) to the exterior of the tube electrode 520 to provide an insulated grip. In order to prevent fiber damage, in some embodiments, a standard fiber-optic strain-relief boot and jacket 526 is used to protect the fiber 531. In some embodiments, the signal-electrode wire 527 is run in a separate cable from the electrical-stimulator electronics 530 to the probe 520. In some embodiments, the ground-electrode wire 528 is run in a separate cable from the remote electrical-stimulator electronics and optical source controller 530 (e.g., the power and control that generates the electrical and laser signal(s)) to the probe 520, while in other embodiments, the optical fiber 521, signal-electrode wire 527, and ground-electrode wire 528 are housed in a single cable that extends from controller 530 to probe 520. In some embodiments, in order to provide a consistent optical energy delivered to the tissue, the fiber is recessed within the tube approximately 1 mm away from the nerve 97 (see FIG. 8). In other embodiments, the distance by which the fiber is recessed is more than 2 mm, or by about 2 mm, 1.6 mm, 1.4 mm, 1.2 mm, 0.8 mm, 0.6 mm, 0.4 mm, 0.2 mm, 100 microns, or 0 mm (i.e., when the recess is said to be 0 mm, the end of the fiber is flush with the end of the tube or cannula). In other embodiments, the fiber tip extends from and beyond the end of the cannula or tube, for example, in some embodiments, by a non-zero amount of no more than 100 microns (0.1 mm), 0.2 mm, 0.4 mm, 0.6 mm, 0.8 mm, 1 mm, 1.2 mm, 1.4 mm, 1.6 mm, or 2 mm or more. In some embodiments that use a metallized coating on the optical fiber for the electrical conductor, the optical fiber extends as a bare optical fiber beyond the end of the metallization by a non-zero amount of no more than 100 microns (0.1 mm), 0.2 mm, 0.4 mm, 0.6 mm, 0.8 mm, 1 mm, 1.2 mm, 1.4 mm, 1.6 mm, or 2 mm or more. If the fiber core diameter is 400 microns, the fluence delivered to the nerve is 2.5 J/cm² with 4 W of peak power over 1 msec, assuming a flat-top profile. (In some embodiments, this peak power is calculated with a Gaussian profile, while in other embodiments, a flat profile is used for the calculation; in some such embodiments, the same calculation method is used that was used for other calculations, such as previously published papers by Vanderbilt University researchers that measure the optical fluence needed for triggering a NAP in the sciatic rat nerve, in order to compare the fluence calculation in the present invention with those papers.) The typical stimulation threshold for the sciatic rat nerve was determined to be about 1 to 2 J/cm².

FIG. 6A is a schematic prior-art graph 610 (adapted from Dale Purves et al., Neuroscience, 3^(rd) ed. page 31) of an electrical-only pulse set for nerve stimulation according to some embodiments of the prior art. Regarding electrical-only stimulation, in some embodiments, a resting nerve has a voltage of about −65 milliVolts (mV) (see Dale Purves et al., Neuroscience, 3^(rd) ed. page 31) to about −75 mV (called the resting potential or polarized voltage), and a CNAP or NAP has an electrical-voltage-change trigger threshold of about +15 mV to about +40 mV above the resting-nerve potential (i.e., of the voltage at the nerve must be “depolarized” by changing its voltage to between about −55 mV and about −30 mV). Failed initiations (e.g., 611, 612, and 613) caused by a lower-than-threshold voltage change or current injected into the cell (e.g., 601 and 602 which hyperpolarize the cell, and 613 which depolarizes the cell but not enough to trigger a NAP) will allow the nerve to return to its resting potential of about −65 to −80 mV in less than about 1 millisecond (ms). A depolarizing electrical signal 603 that is below threshold will cause a depolarized response 613 that does not trigger a NAP. A depolarizing electrical signal 604 that is at or slightly above threshold will cause a depolarized response 614 that does trigger a NAP, because if a sufficient electrical voltage or current is applied (e.g., signal 604), the nerve-stimulation signal will trigger a nerve action potential 614, and once triggered, the NAP typically enters a rising phase that takes the voltage to between about +40 mV and about +50 mV in about 1 ms, and the voltage then drops to between about −40 mV and about −90 mV in about 1 ms. If the stimulation voltage pulse is much higher than the threshold voltage change or current injection (e.g., stimulation signal pulses 605 or 606), the NAP will be triggered more quickly (perhaps 1 ms) or a plurality of NAPs will be triggered (e.g., 615 or 616 if the triggering pulse remains active for a sufficient length of time) than if a slowly-rising minimum threshold voltage change is applied (which could take up to about 10 ms or more to trigger the NAP).

FIG. 6B is a schematic graph 620 of a hybrid-electrical-and-optical pulse set for nerve stimulation according to some embodiments of the invention. As described above for FIG. 6A, a hyperpolarizing electrical signal 601 will cause a hyperpolarized response 611 that does not trigger a NAP. A depolarizing electrical signal 603 that is below threshold will cause a slightly depolarized response 613 that does not trigger a NAP. An optical signal 623 that is below threshold will also cause a depolarized response 643 (similar to the response 613 to a sub-threshold electrical signal 603) that also does not trigger a NAP. However, depolarizing electrical signal 634 that if delivered alone would be below threshold delivered substantially simultaneously along with an optical signal 624 that if delivered alone would be below threshold will, when both are delivered together in time, cause a depolarized response that does trigger a NAP 644. A larger and/or longer depolarizing electrical signal 635 (e.g., one that if delivered alone would be at threshold) along with a larger and/or longer optical signal 625 (e.g., one that if delivered alone would be at threshold) will cause two or more depolarized responses that each trigger a NAP 645 (e.g., the two NAPs 645 shown here). In some embodiments, a larger and/or longer depolarizing electrical signal 636 (e.g., one that if delivered alone would be above threshold) along with a below-threshold optical signal 626 (e.g., one that if delivered alone would be below threshold) will cause two or more depolarized responses that each trigger a NAP 646 (e.g., the three NAPs 646 shown here). In some embodiments, a below-threshold depolarizing electrical signal 637 (e.g., one that if delivered alone would be below threshold) along with an above-threshold optical signal 627 (e.g., one that if delivered alone would be above threshold) will cause two or more depolarized responses that each trigger a NAP 647 (e.g., the three NAPs 647 shown here).

In some embodiments of the present invention that uses both electrical and optical signals for stimulation, the electrical signal is pulsed. In some embodiments, the pulsed electrical signal is applied simultaneously with an optical pulse of substantially the same duration. In other embodiments, the electrical pulse can be longer or shorter than the optical pulse.

In some embodiments, the electrical pulse is applied starting before the optical pulse. In some such embodiments, the electrical pulse continues for the duration of the optical pulse. In other embodiments, the electrical pulse ends before or as the optical pulse starts. In other embodiments, the electrical pulse ends as or after the optical pulse ends. In some embodiments, the main electrical pulse is of such long duration and is applied sufficiently early relative to the optical pulse as to essentially act as a DC electrical preconditioning voltage. In some embodiments, a DC electrical bias is applied before the main electrical pulse is applied.

In other embodiments, the optical pulse is applied starting before the electrical pulse. In some such embodiments, the optical pulse continues for the duration of the electrical pulse. In other embodiments, the optical pulse ends before or as the electrical pulse starts. In other embodiments, the optical pulse ends as or after the electrical pulse ends. In some embodiments, the main optical pulse is of such long duration and is applied sufficiently early relative to the electrical pulse as to essentially act as a DC optical preconditioning voltage. In some embodiments, a DC optical bias is applied before the main optical pulse is applied.

In some embodiments of the present invention, the stimulus electrical pulse and/or electrical DC bias are limited to a value that is generally lower than required (i.e., lower than the minimum threshold voltage change) for electrical-only triggering of a nerve action potential. The nerve would then return to its resting potential after such a failed electrical stimulation. That is, the electrical signal applied would not trigger a NAP if the optical signal is not also applied. In other embodiments, the electrical signal applied by the present invention would be sufficient to usually trigger the NAP, but would or occasionally could take too long or occasionally would and occasionally would not trigger a NAP if used alone, but when applied with the optical signal of the present invention provides a more precise timing and/or reliable triggering of the NAP signal. In other embodiments, the electrical signal is applied to speed up the recovery time for the later triggering of another NAP (a nerve typically requires a certain amount of time to reset or recover after one NAP occurs, and the electrical signal is applied in such a manner as not to trigger the next NAP but to shorten the time needed between NAPs by assisting ion transport across the nerve cell membrane).

In some embodiments, the optical signal includes a “DC” optical component (i.e., a long pulse or essentially constant background amount of light applied before the main optical pulse(s)). In some embodiments, the “DC” optical component also reduces the power that would otherwise be required to trigger the desired NAP.

In some embodiments, the optical pulse and/or “DC” optical component are limited to a power and/or energy value that is generally lower than that required for optical-only triggering of a nerve action potential. That is, the optical signal would not trigger a NAP if the electrical signal is not applied. However, when applied simultaneously or at least close enough in time the combination of the relatively small electrical and optical stimulation signals (that is, each being smaller than is normally required to trigger the NAP) is sufficient to trigger a NAP.

In conventional electrical stimulation even the smallest electrical probe will apply the electrical signal to a relatively large number of nerves and thus using only electrical stimulation it is difficult to trigger a NAP in only one particular nerve or just a few nerves. On the other hand, the delivery of optical stimulation can be quite precise by using optical fibers and focussing optics, but requires relatively large amounts of optical power. One benefit of the present invention, using substantially simultaneous relatively small electrical and optical stimulation signals, is that the risk of optical damage to the cell is reduced, since lower optical power is required, while the precision delivery of the stimulation by the optical signal still allows a NAP in a particular nerve to be triggered while avoiding also triggering NAPs in surrounding nerves.

In some embodiments, the electrical stimulation can be applied external to the skin of the patient, such as is done with transcutaneous electrical nerve stimulation (TENS) devices. In some embodiments, such a device is used, but the electrical signal is reduced to a level that does not trigger a NAP. An optical signal is simultaneously (or, as discussed above, substantially simultaneously) applied to the desired tissue to be stimulated. In some such embodiments, the optical signal is delivered using an implanted optical fiber. In other embodiments, the optical signal is applied from outside the body and through the skin of the patient.

FIG. 7A is a perspective schematic view and block diagram of a hybrid-electrical-and-optical system 700 for highly selective nerve stimulation according to some embodiments of the invention. FIG. 7B is an enlarged perspective schematic view and block diagram of a portion of the hybrid-electrical-and-optical system 700 of FIG. 7A. In some embodiments, hybrid-electrical-and-optical system 700 includes a nerve-interface unit 720 that is clamped onto or around a nerve 11. In some embodiments, nerve-interface unit 720 includes a plurality of fine-pitched electrodes (such as have been used in FINE-type electrodes described above). In some embodiments, nerve-interface unit 720 is configured to snap together with an opening having a height that is smaller than its width to slightly compress the nerve 11. In some embodiments, the electrode portion of nerve-interface unit 720 is constructed in a manner similar to U.S. Pat. No. 6,456,866 to Tyler et al. (described above), but has many more electrodes and also includes a plurality of lasers (such as VCSELs) in the nerve-interface unit 720, or is connected by a plurality of optical fibers to a plurality of externally located lasers.

In some embodiments, nerve-interface unit 720 includes a first plurality of fine-pitched electrodes 723 on one side (e.g., the upper-front side) and a second plurality of fine-pitched electrodes 724 on an opposite side across the nerve 11, configured to generate one or more narrow stripes of electric field 788 transverse to the nerve 11 (e.g., by applying a voltage between one of the upper front electrodes 723 and one of the lower front electrodes 724, as shown in FIG. 7B).

In some embodiments, nerve-interface unit 720 includes a first plurality of fine-pitched electrodes 723 on one side (e.g., the upper-front side) (and/or a second plurality of fine-pitched electrodes 724 on one side (e.g., the lower-front side)) and a third plurality of fine-pitched electrodes 725 on an opposite side (e.g., the upper-back side) (and/or a second plurality of fine-pitched electrodes 726 on an opposite side (e.g., the lower-back side)) further up the nerve 11, configured to generate one or more narrow stripes of electric field 787 longitudinally along the nerve 11 (e.g., by applying a voltage between one of the upper front electrodes 723 and one of the upper back electrodes 725, as shown in FIG. 7A). In some embodiments, by providing a plurality of such finely pitched electrodes on opposite sides of nerve 11 as well as spaced longitudinally along the nerve 11, the direction across and along the nerve can be precisely controlled. In some embodiments, electrical-pulse control device 712 (under the control of system controller 711) drives electrical signals along conductors 722 to drive the electrodes 723, 724, 725, and/or 726 for a portion of the nerve stimulation (the electrical modality of the two-modality protocol).

In addition, in some embodiments, nerve-interface unit 720 includes a first plurality of fine-pitched optical emitters 732 on one side (e.g., the lower middle) of unit 720 as shown in FIG. 7B. In some embodiments, optical emitters 732 include ends of a plurality of optical fibers (used to carry signals 731, which in this case are optical signals traveling to the probe, wherein the optical signals have been generated in controller 713) that are coupled to laser emitters (e.g., in some embodiments, VCSELs that are each coupled to one or more of the plurality of optical fibers) in optical controller 713 at one end and that emit light within unit 720 directed toward a particular nerve axon (sub-fascicular stimulation) or fascicle (whole-fascicle stimulation). In some such embodiments, only one optical fiber is driven in order to evoke a NAP in a particular fiber at a time, while in other embodiments, a plurality of fibers can be driven to evoke a broader response (e.g., triggering NAPs in separate axons).

In other embodiments, signals 731 are electrical signals from optical controller 713 that drive one or more of the plurality of light emitters (e.g., in some embodiments, vertical-cavity surface-emitting lasers (VCSELs) 732) that are mounted to unit 720, such as shown in FIG. 7B. Note that signals 731, in some embodiments, are optical signals carried by optical fibers from lasers in controller 713 to fiber-end emitters in probe 720 (as shown in FIG. 7A), while in other embodiments, signals 831 are electrical signals from optical controller 713 that carry electricity drive one or more of the plurality of light emitters (e.g., in some embodiments, (VCSELs), as shown in FIG. 7B). In some such embodiments, only one VCSEL 732 is driven in order emit a light pulse 789 (e.g., a light pulse that would be sub-threshold but for the applied electric field 788 as shown in FIG. 7B, or in the case of FIG. 7A, the longitudinal electric field 787) to evoke a NAP in a particular nerve fiber at a given time, while in other embodiments, a plurality of VCSELs can be driven simultaneously or in close temporal proximity to evoke a broader response. In the situation where it is desired to evoke simultaneous NAPs in a plurality of different fibers, one or more of the plurality of possible pairs or subsets of electrodes (e.g., a selected one of the electrodes 723) might be connected to an electrical ground and simultaneously a non-zero sub-threshold signal voltage is applied to one of the electrodes 724 (which generates a transverse voltage across a subset of the nerve 11), or one of the electrodes 725 (which generates a longitudinal voltage along a length of a subset of the nerve 11), or one of the electrodes 726 (which generates a transverse and longitudinal voltage across and along a length of a subset of the nerve 11), or one of the other electrodes 723 (which generates a side-to-side (somewhat transverse) voltage across the top of a subset of the nerve 11), is/are driven with a sub-threshold voltage pulse to precharge the various nerves to be stimulated and two or more optical emitters are driven to generate spatially separated optical pulses to trigger the desired subset of nerves to obtain the desired simultaneous NAPs. In the situation where it is desired to evoke a sequence of NAPs in a plurality of different nerve fibers, one or more of the plurality of possible pairs or subsets of electrodes is/are driven with one or a sequence of sub-threshold voltage pulses to precharge the various nerves to be stimulated in the sequence desired and two or more optical emitters are driven in a sequence to generate temporally and/or spatially separated optical pulses to trigger the desired subset of nerves to obtain the desired sequence of NAPs.

By selectively applying a sub-threshold voltage pulse from one of the electrodes (723, 724, 725, or 726) to another of the electrodes (723, 724, 725, or 726) to generate an electrical field, and then selectively applying a narrow-spot optical pulse, the present invention provides precise control to trigger a sub-fascicular NAP.

In some embodiments, the electrical signal is applied between a first electrode and a second electrode that are located directly across from one another in probe 720 (e.g., such as shown in FIG. 7A, from the electrode 723 that is located fifth-most from the left-hand side of the front top row, to the electrode 724 that is located fifth-most from the left-hand side of the front bottom row) to generate electric field 788 of FIG. 7A. In some embodiments, the electrical signal is applied between a first electrode and a third electrode that are located axially across from one another in probe 720 (e.g., from the electrode 723 that is located third-most from the left-hand side of the top row, to the electrode 725 that is located third-most from the left-hand side of the back top row) to generate electric field 787 of FIG. 7A. Note that in some embodiments, only one of the two electrical fields shown in FIG. 7A would be applied at any one time.

In other embodiments, the electrical signal is applied between a first electrode and a second electrode that are located not only across but diagonally across from one another in probe 720 (e.g., from the electrode 723 that is located second-most from the left-hand side of the front top row, to the electrode 724 that is located fifth-most from the left-hand side of the front bottom row, or from the electrode 725 that is located second-most from the left-hand side of the back top row, to the electrode 726 that is located fifth-most from the left-hand side of the back bottom row). In some embodiments, the electrical signal is applied between a first electrode and a third electrode that are located not only axially but diagonally transverse as well as axially across from one another in probe 720 (e.g., from the electrode 723 that is located second-most from the left-hand side of the top row, to the electrode 725 that is located seventh-most from the left-hand side of the back top row or to the electrode 726 that is located ninth-most from the left-hand side of the back bottom row). Note that in some embodiments, the electric field can be applied from any one electrode to any other electrode in probe 720, in order to enhance selectivity and apply the electric field to the smallest amount of tissue possible with a given probe. In yet other embodiments, the electrode is applied from a plurality of electrode to a plurality of other electrodes (e.g., from the electrodes 723 that are located second-most, third-most and fourth-most from the left-hand side of the front top row, to the electrodes 724 that are located third-most, fourth-most and fifth-most from the left-hand side of the front bottom row) in order to provide a more uniform electric field across the spot of tissue to be optically stimulated with a laser pulse of a given spot size and penetration depth.

In some embodiments, the optical emitters are located in both the top and bottom of probe 720, and their respective optical energy or power are limited in order to provide greater selectivity (i.e., the top-side optical emitters would be driven with an optical signal having a limited penetration depth in order to trigger responses only in the top portion of the nerve 11, and the bottom-side optical emitters would be driven with an optical signal having a limited penetration depth in order to trigger responses only in the bottom portion of the nerve 11). In some embodiments, both the optical signal and the electrical signal are limited in power and area in order to further enhance the selectivity of the portion of the nerve 11 that is triggered to have a NAP.

In essence, the probe 720 of FIG. 7A includes two-dimensional array (e.g., two rows of a Cartesian grid) of electrodes is provided on both opposing inner surfaces of probe 720 (e.g., the two rows on the top inner surface: electrodes 723 and electrodes 725 shown in FIG. 7A and two rows on bottom inner surface: electrodes 724 and electrodes 726 shown in FIG. 7A). In some such embodiments, the electrical signal is applied between one or more selected top electrodes and one or more selected bottom electrodes (in some embodiments, these can be directly across from one another, while in other embodiments, there is a transverse and/or longitudinal (axial) diagonal component between the selected electrodes to which the electrical field is applied. In other embodiments, one or more additional rows are provided on the top inner surface and the bottom inner surface so that a grid of electrodes is provided on the entire top inner surface between the edge where electrodes 723 and the edge where electrodes 725 are shown in FIG. 7A and across the entire bottom inner surface between the edge where electrodes 724 and the edge where electrodes 726 are shown in FIG. 7A.

In other embodiments, probe 720 of FIG. 7A includes two-dimensional array (e.g., two or more rows of a Cartesian grid) of electrodes is provided on one surface of probe 720 (e.g., the electrodes 723 and the electrodes 725 shown in FIG. 7A), while a single planar electrode is placed on the opposite inner surface (e.g., across the entire bottom inner surface between the edge where electrodes 724 and the edge where electrodes 726 are shown in FIG. 7A), and the electrical signal is applied from one or more of the top electrodes and the single bottom electrode.

In some embodiments, the combination of electrodes needed to provide the electrical field needed for triggering a NAP in a particular nerve is empirically determined by trying different combinations of electrodes as pairs until the desired nerve response is evoked, and similarly the optical emitter that best evokes the desired nerve response is empirically determined by trying different combinations of optical emitters and electrodes. In some embodiments, one or more pairs of the electrodes (723, 724, 725, or 726) are also or alternatively used to measure the resulting NAP generated by the electrical and optical stimulation. In some embodiments, once the desired nerve response and/or sensed NAP is detected as a result of the stimulation, the empirically determined combination of electrodes and optical emitters that evoke that desired response is stored in system controller 711.

In some embodiments, one or more of the circuits for controller 711, electrical stimulator 712 and/or optical stimulator 713 are implemented in electronic chips that are mounted within nerve-interface unit 720 as shown in FIG. 7C.

FIG. 7C is a perspective schematic view and block diagram of a hybrid-electrical-and-optical system 703 having one or more embedded electronic and/or optical chips according to some embodiments of the invention. In some embodiments, system 703 is much the same as system 700 described above, except that nerve-interface unit 740 includes a plurality of integrated-circuit (IC) chips (corresponding to nerve-interface unit 720 described above), some or all of the circuitry of controller 711 is implemented in one or more IC chips 741, and/or some or all of the circuitry of electric-pulse generator 712 is implemented in one or more IC chips 742, and/or some or all of the circuitry of optical-pulse controller and/or generator 713 is implemented in one or more IC chips 743. In some embodiments, two or more of chips 741, 742, and 743 are merged into a single integrated-circuit chip. In some embodiments, a battery (not shown) is also embedded in nerve-interface unit 740. In other embodiments, the battery and/or some of the circuitry is implemented in a separate implanted controller unit. In some embodiments, the system controller 711 (in chip 741) is wirelessly reprogrammable (e.g., by radio waves, laser light, or other suitable communications channels), in order to customize its functionality.

In a given fascicle, there are typically fifteen (15) times as many sensory-nerve pathways (sending signals to the brain) as motor-nerve pathways (sending signals from the brain to the muscles). In some embodiments, the present invention provides a prosthesis having a plurality of sensors that generate signals based on measured environmental factors, and these signals are converted to electrical signals 722 and optical signals 731 to trigger NAPS in the appropriate sensory-nerve pathways to convey this information to the patient. In some embodiments, the array of electrodes (723, 724, 725, and 726) are used to detect particular motor-nerve signals that are then converted to signals to control actuators and motors in the prosthesis, such as shown in FIG. 10B and described below. In some embodiments, one or more chips are provided in nerve-interface unit 740 that each provide a plurality of VCSELs 732, each of which can be individually controlled to emit the required optical pulses 789 (as shown in FIG. 7B).

In some embodiments, the plurality of electrodes includes a first subset (electrodes 723 and electrodes 724) that are located along a first perimeter (e.g., the front-side perimeter) of a nerve-interface unit 720 that surrounds the nerve 11 of a human patient 99. In some embodiments, the plurality of electrodes further includes a second subset (electrodes 725 and electrodes 726) that are located along a second perimeter (e.g., the back-side perimeter) of the nerve-interface unit that is longitudinally spaced (e.g., by the longitudinal thickness of nerve-interface unit 720) from the first perimeter. In some embodiments, the center-to-center spacings of the electrodes are in a range of between 50 microns and about 1000 microns (0.05 to 1.0 millimeters).

In some embodiments, the plurality of optical emitters includes a first subset (optical emitters 732) that are located along a first perimeter (e.g., the bottom half of an inside perimeter) of nerve-interface unit 720 that surrounds the nerve 11 of a human patient 99. In some embodiments, the plurality of optical emitters further includes a second subset (not shown here) that are located along a second perimeter (e.g., along the top half of the inside perimeter opposite the bottom inside perimeter) of the nerve-interface unit.

Evidence seems to show that the superposition of the two modalities (i.e., the electrical stimulation and the optical stimulation) is not a simple linear superposition. In some embodiments, optimization of pulse durations, synchronized timing of the two pulse modalities, spatial distribution of the electrical field relative to the laser-induced thermal field, as well as other variables, are addressed empirically. In some embodiments, this optimization significantly reduces the IRNS threshold requirements with a substantially smaller percentage of the electrical stimulus threshold. In some such embodiments, this optimization accelerates the clinical implementation of neuroprostheses with highly precise neural interfaces.

FIG. 8 is a perspective view and block diagram of a hybrid-electrical-and-optical system 800 for nerve stimulation according to some embodiments of the invention. In some embodiments, the electrical signal is applied using one delivery probe 824 while the optical signal is applied using a separate or substantially separate delivery probe 832 (i.e., using two or more separate probes or probe ends). In some embodiments, a system controller 811 controls the timing and other characteristics of the electrical signal and the optical signal (such as portrayed in insert graphs showing hypothetical plots of intensity (i) as a function of time (t) for an electrical-pulse signal 881 and for an optical-pulse signal 882). In some embodiments, such as shown in FIG. 8, one or both of the electrical delivery probe 824 and the optical delivery probe 832 are invasive (e.g., fully implanted) and/or deliver the electrical signal and the optical signal internal to the body of the patient 99—in some embodiments, delivering the signals to a particular selected set of nerve pathways 97 that is the set of nerve pathways to be stimulated within nerve bundle 98. In some embodiments, the selected set of nerve pathways 97 is a small subset (e.g., in some embodiments, less than 5%; less than 10%, less than 15%, less than 20%, or less than 25%, less than 30%, less than 40%, or less than 50%) of the nerve pathways within a given fascicle or nerve bundle 98, while in other embodiments, selected set of nerve pathways 97 includes substantially all of the nerve pathways within the given fascicle 98. In some other embodiments, one or both of the electrical-signal generator 812 and the optical signal generator 813 are located external to the body of the patient. In some other embodiments, one or both of the electrical signal generator and its associated electrical probe(s) and the optical signal generator and its associated optical probe(s) are implanted and/or located internal to the body of the patient. In some embodiments, electrical-signal generator 812 is connected by wire 821 to ground/return probe 823 and electrical-signal generator 812 is connected by wire 822 to electrical-signal probe 824. In some embodiments, the electrical probe 824 is at least partially covered with a dielectric/electrical-insulator material 825. In some embodiments, an optical cable 831 includes one or more optical fibers to deliver light to optical probe 832.

FIG. 9 is a perspective view and block diagram of a hybrid-electrical-and-optical system 900 for nerve stimulation according to some embodiments of the invention. In some embodiments, the optical signal and the electrical signal are both delivered through the same probe 420, such as one of those described in U.S. patent application Ser. No. 12/018,185 filed Jan. 22, 2008, titled “HYBRID OPTICAL-ELECTRICAL PROBES,” by the inventors of the present invention. For example, some embodiments use an optical fiber 931 embedded in a hollow electrically conductive pipe or cannula 924 such as one made of stainless steel or other bio-compatible metal or other electrical conductor. In some embodiments, the optical fiber 931 or its signal-carrying core terminates short of the end of the hollow electrical conductor 924. In some embodiments, most or all of the length of the outside of the electrical conductor is coated with a bio-compatible insulator 925 (such as a conformal polymer coating) that leaves an exposed electrically conductive tip 924 used to apply the electrical signal to the patient 99's tissue next to or in the particular selected nerve 97 to be stimulated (i.e., either the outside or the inside of the hollow conductive tip 924 provide a conductive surface that applies a voltage to the surrounding tissue).

In other embodiments, the electrical-signal conductor 924 is formed by plating, sputtering, evaporating, and/or otherwise depositing a metal or other conductor onto an optical fiber 931. In some such embodiments, most or all of the length of the outside of the conductor is coated with a bio-compatible insulator (such as a conformal polymer coating) that leaves an exposed conductive tip used to apply the electrical signal to the patient 99's tissue next to or in the nerve to be stimulated 97. In some embodiments, a visible light laser device 914 (e.g., one that emits red light at 630-nm wavelength or green light at 532-nm wavelength or other suitable visible light (400-to-700-nm) wavelength) is used to provide a visible indicator light that is combined (e.g., using a dichroic mirror or other combiner 915) with the infrared (IR) stimulation light from emitter 813, in order that the visible light provides visual feedback to the operator showing where the IR signal 89 will be delivered. This is particularly useful in embodiments where a focussing optic 939 at the end of the optical fiber causes the nerve-stimulation signal light 89 (in some embodiments, along with a co-propagating visible indicator light) to be projected a short distance from the end of probe 920. In some embodiments, a plurality of different IR wavelengths are used (e.g., combined into a single signal) in order to customize (i.e., control and/or change) the penetration depth of the stimulation signal light 89.

One component useful to make the system more functional, in some embodiments, is a probe (such as probe 520 or probe 920) that integrates both the electrical and optical (generating infrared optical signals for nerve stimulation and/or visible optical signals for indicating where the infrared is or will be pointing) stimulators. Some embodiments provide such an EO probe that can be used in the EO system. In other embodiments, two or more probes are used to deliver the electrical and optical signals to the site where stimulation is desired. Insert graphs 981 and 982 in FIG. 9 show hypothetical plots of intensity (i) as a function of time (t) for an electrical-pulse signal 981 that alone is sub-threshold (somewhat less than a signal sufficient) for initiating an NAP, and for an optical-pulse signal 982 that alone is sub-threshold for initiating an NAP.

FIG. 10A is a system schematic of the electrical-optical-hybrid stimulator 1001 according to some embodiments. In some embodiments, an EEG (electroencephalograph) system 1010 is used to record electrical activity of areas of the brain and/or other nerve signals. Other aspects and referenced elements of FIG. 10A are as described above for FIG. 7A, FIG. 7B, FIG. 8 and FIG. 9. In some embodiments, the sensing electrode is formed from two or more of the electrodes of the fine-pitched electrode array of the electrodes 723, 724, 725, and 726.

FIG. 10B is a system schematic of the electrical-optical-hybrid stimulator and prosthesis system 1002 according to some embodiments of the invention. In some embodiments, prosthesis system 1002 includes the electrical-optical-hybrid stimulator 700 as described above for FIG. 7A and FIG. 7B, as well as an interface that is connected to prosthesis 1020. In some embodiments, sensed signals from electrodes 723, 724, 725, and/or 726 (i.e., sensed motor-nerve signals) are used to control actuators and/or motors in prosthesis 1020 (e.g., in some embodiments, an artificial or “bionic” arm or leg, wherein the motors control the various rotations, extensions, opening, closing and other motor functions of the arm being replaced), while sensors in the prosthesis 1020 generate signals 1011 based on measurements of the environment (e.g., the weight, texture, temperature, moistness, or other attributes of something being touched or grasped), and these sensed signals are used by controller 711 to generate the appropriate electrical and optical signals to trigger NAPs in the various different sensory nerves 97 in order to convey the sensed information as feedback to the brain of the patient 99 connected to the prosthesis system 1002. In some embodiments, most of system 1002 is implanted within patient 99.

In some embodiments, the probe is connected to both an optical stimulator such as the Capella™ model R1850 infrared optical-signal nerve stimulator (available from Lockheed Martin Aculight Corporation, 22121 20th Avenue S.E., Bothell, Wash. 98021 USA) and an electrical nerve stimulator such as an S88 Grass electrical stimulator (available from Astro-Med Inc., Grass Technologies Product Group, 600 East Greenwich Avenue, West Warwick, R.I. 02893 USA) in order to provide both types of stimulus. In addition to the two stimulators, a pulse generator is used to trigger each stimulator with a single input trigger in some embodiments. In some embodiments the pulse generator also has the ability to initiate the electrical stimulation first and then trigger the optical stimulation.

In some embodiments, the present invention provides a method for fine-pitched electrical and optical stimulation that includes generating and applying both a fine-pitched electrical stimulation signal to a portion of a nerve, and a fine-pitched optical stimulation signal to the portion of the nerve in order to trigger a nerve action potential (NAP) in vivo. In some embodiments, the method further includes compressing the nerve in order to space apart certain subportions of the nerve in order to improve selectivity of the applied electrical and optical signals. In some embodiments, the applying of the fine-pitched electrical stimulation includes applying a voltage in a direction that is transverse across the portion of the nerve. In some embodiments, the applying of the fine-pitched electrical stimulation includes applying a voltage in a direction that is longitudinal along the portion of the nerve. In some embodiments, the applying of the fine-pitched electrical stimulation includes applying a voltage in a direction that is both transverse across and longitudinal along the portion of the nerve.

Some embodiments of the method further include detecting a nerve action potential (NAP). In some embodiments, the detection of the NAP is used as feedback control to the generating and applying of the electrical stimulation signal and the optical stimulation signal.

In some embodiments, the fine-pitched electrical signal is applied to a selected subset (e.g., to a pair) selected from a plurality of electrodes that are spaced on a center-to-center distance of about 1000 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 500 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 300 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 200 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 100 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 50 microns or less. In some embodiments, the plurality of electrodes includes a first subset that is located along a first perimeter of a nerve-interface unit that surrounds the nerve of a human patient. In some embodiments, the plurality of electrodes further includes a second subset that is located along a second perimeter of the nerve-interface unit that is longitudinally spaced from the first perimeter.

In some embodiments, the fine-pitched optical signal is launched from to a selected subset (e.g., from one) selected from a plurality of optical emitters that are spaced on a center-to-center distance of about 1000 microns or less. In some embodiments, the plurality of optical emitters includes a first subset that are spaced apart from one another and located along a first perimeter (e.g., the bottom half of an inside perimeter) of a nerve-interface unit that surrounds the nerve of a human patient. In some embodiments, the plurality of optical emitters further includes a second subset that are located along a second perimeter (e.g., along the top half of the inside perimeter opposite the bottom inside perimeter) of the nerve-interface unit. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 500 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 300 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 200 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 100 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 75 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 50 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 25 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 10 microns or less.

In some embodiments, the present invention provides an apparatus for fine-pitched electrical and optical stimulation that includes an electrical-signal generator that is coupled to a plurality of spaced-apart electrodes and operable to selectively apply a fine-pitched electrical stimulation signal to a portion of a nerve, and an electrical-signal generator operatively coupled to emit an optical-stimulation signal to the portion of the nerve in order to trigger a nerve action potential (NAP) in vivo. In some embodiments, the apparatus is configured to compress the nerve in order to space apart certain subportions of the nerve in order to improve selectivity of the applied electrical and optical signals. In some embodiments, a subset of the plurality of spaced-apart electrodes is configured to apply a voltage in a direction that is transverse across the portion of the nerve. In some embodiments, a subset of the plurality of spaced-apart electrodes is configured to apply a voltage in a direction that is longitudinal along the portion of the nerve. In some embodiments, a subset of the plurality of spaced-apart electrodes is configured to apply a voltage in a direction that is both transverse across and longitudinal along the portion of the nerve.

Some embodiments of the apparatus further include a nerve action potential (NAP) detector configured to sense a NAP and to output a signal representative of the NAP. In some embodiments, the signal from the detector is coupled to the electrical-signal generator and the optical-signal generator and used as feedback control to the generation and application of the electrical-stimulation signal and the optical-stimulation signal.

In some embodiments, the fine-pitched electrical signal is applied to a selected subset (e.g., to a pair) selected from a plurality of electrodes that are spaced on a center-to-center distance of about 1000 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 500 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 300 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 200 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 100 microns or less. In other embodiments, the center-to-center spacing of the plurality of electrodes is about 50 microns or less. In some embodiments, the plurality of electrodes includes a first subset that is located along a first perimeter of a nerve-interface unit that surrounds the nerve of a human patient. In some embodiments, the plurality of electrodes further includes a second subset that is located along a second perimeter of the nerve-interface unit that is longitudinally spaced from the first perimeter.

In some embodiments, the fine-pitched optical signal is launched from to a selected subset (e.g., from one) selected from a plurality of optical emitters that are spaced on a center-to-center distance of about 1000 microns or less. In some embodiments, the plurality of optical emitters includes a first subset that are spaced apart from one another and located along a first perimeter (e.g., the bottom half of an inside perimeter) of a nerve-interface unit that surrounds the nerve of a human patient. In some embodiments, the plurality of optical emitters further includes a second subset that are located along a second perimeter (e.g., along the top half of the inside perimeter opposite the bottom inside perimeter) of the nerve-interface unit. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 500 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 300 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 200 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 100 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 75 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 50 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 25 microns or less. In other embodiments, the center-to-center spacing of the plurality of optical emitters is about 10 microns or less.

In some embodiments, the apparatus further includes a stimulation-to-nerve mapping software that controls outputting of various electrical and optical signals and detects (e.g., using indications from the patient) to empirically map which signals stimulate which nerve pathways.

In some embodiments, the present invention provides a method that includes applying a combination of both an electrical stimulation signal and an optical stimulation signal to trigger a nerve action potential (NAP) in vivo. In some embodiments, the present invention provides a method that includes generating an electrical stimulation signal and an optical stimulation signal; and applying a combination of both the electrical stimulation signal and the optical stimulation signal to a living animal to trigger a nerve action potential (NAP) in vivo.

In some embodiments, the optical stimulation signal is of a nature such that if applied alone the optical signal has a low probability of triggering a NAP. In some such embodiments, the optical-only probability is no more than 0.5 (i.e., wherein a NAP occurs on no more than 50% of applied optical signals). In some such embodiments, the probability is no more than 0.4 (a NAP occurring on no more than 40% of applied optical signals). In some such embodiments, the probability is no more than 0.3 (a NAP occurring on no more than 30% of applied optical signals). In some such embodiments, the probability is no more than 0.25 (a NAP occurring on no more than 25% of applied optical signals). In some such embodiments, the probability is no more than 0.2 (a NAP occurring on no more than 20% of applied optical signals). In some such embodiments, the probability is no more than 0.15 (a NAP occurring on no more than 15% of applied optical signals). In some such embodiments, the probability is no more than 0.1 (a NAP occurring on no more than 10% of applied optical signals). In some such embodiments, the probability is no more than 0.05 (a NAP occurring on no more than 5% of applied optical signals). In some such embodiments, the probability is no more than 0.01 (a NAP occurring on no more than 1% of applied optical signals).

In some embodiments, the electrical stimulation signal is of a nature such that if applied alone the electrical signal also has a low probability of triggering a NAP. In some such embodiments, the electrical-only probability is no more than 0.5 (a NAP occurring on no more than 50% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.4 (a NAP occurring on no more than 40% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.3 (a NAP occurring on no more than 30% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.25 (a NAP occurring on no more than 25% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.2 (a NAP occurring on no more than 20% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.15 (a NAP occurring on no more than 15% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.1 (a NAP occurring on no more than 10% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.05 (a NAP occurring on no more than 5% of applied electrical signals). In some such embodiments, the electrical-only probability is no more than 0.01 (a NAP occurring on no more than 1% of applied electrical signals).

Some embodiments of the method further include selectively applying a visible indication light signal that indicates a location that the optical stimulation signal is to be applied. Some embodiments of the method further include using a hybrid probe having an optical fiber inserted in an electrically conductive cannula; applying the optical-stimulation signal through the optical fiber; and applying the electrical-stimulation signal through the cannula. Some embodiments of the method further include using a second probe to obtain an electrical signal representative of the triggered NAP. In some embodiments, the hybrid probe further includes an electrode that is electrically separate from the cannula, and the method further includes using the electrode to obtain an electrical response signal representative of the triggered NAP. In some embodiments, the method further includes using the cannula to obtain an electrical response signal representative of the triggered NAP.

In some embodiments of the method, a signal representative of the electrical stimulation signal is subtracted from a signal obtained using the cannula to obtain the electrical response signal representative of the triggered NAP.

Some embodiments of the method further include using a hybrid probe having an optical fiber that has a metallization layer applied to the optical fiber; applying the optical-stimulation signal through the optical fiber; and applying the electrical-stimulation signal through the metallization layer. Some embodiments of the method further include using a second probe to obtain an electrical response signal representative of the triggered NAP. In some embodiments, the hybrid probe further includes an electrode that is electrically separate from the metallization layer, and the method further includes using the electrode to obtain an electrical response signal representative of the triggered NAP. Some embodiments of the method further include using the metallization layer to obtain an electrical response signal representative of the triggered NAP. In some embodiments, the applying of the combination of both the electrical stimulation signal and the optical stimulation signal includes using a plurality of electrodes configured to selectively apply the electrical stimulation signal in a direction that is both transverse and axial to a nerve pathway.

In some embodiments, the present invention provides an apparatus that includes an electrical-stimulation-signal source configured to selectively output an electrical stimulation signal; an optical-stimulation-signal source configured to selectively output an optical stimulation signal; and a controller operatively coupled to the electrical-stimulation-signal source and to the optical-stimulation-signal source and configured to control them to trigger a nerve action potential (NAP) in vivo, in animals, and in particular, animals who are human. In some embodiments of the apparatus, the optical stimulation signal is of a nature such that if applied alone the optical stimulation signal has a low probability to trigger a NAP (wherein the low probability is as described above). In some embodiments of the apparatus, the electrical stimulation signal is of a nature such that if applied alone the electrical stimulation signal has a low probability to trigger a NAP (wherein the low probability is as described above). In some embodiments of the apparatus, the optical stimulation signal is infrared, and the apparatus further includes a visible-indication-light-signal source configured to project visible light to indicate a location that the optical stimulation signal is to be applied.

Some embodiments of the apparatus further include a hybrid probe having an optical fiber inserted in an electrically conductive cannula, wherein the optical-stimulation signal is applied through the optical fiber and the electrical-stimulation signal is applied through the cannula. Some embodiments of the apparatus further include a second probe configured to obtain an electrical signal representative of the triggered NAP. In some embodiments of the apparatus, the hybrid probe further includes an electrode that is electrically separate from the cannula, wherein the electrode is configured to obtain an electrical signal representative of the triggered NAP. In some embodiments of the apparatus, the cannula is used to obtain an electrical signal representative of the triggered NAP.

In some embodiments of the apparatus, the apparatus is configured to subtract a signal representative of the electrical stimulation signal from a signal obtained using the cannula to obtain the electrical signal representative of the triggered NAP.

Some embodiments of the apparatus further include a hybrid probe having an optical fiber that has a metallization layer applied to the optical fiber, wherein the optical-stimulation signal is applied through the optical fiber and the electrical-stimulation signal is applied through the metallization layer. Some such embodiments further include a second probe configured to obtain an electrical signal representative of the triggered NAP. In some embodiments, the hybrid probe further includes an electrode that is electrically separate from the metallization layer, and is configured to obtain an electrical signal representative of the triggered NAP. In some embodiments, the apparatus is configured to use the metallization layer to obtain an electrical signal representative of the triggered NAP. Some embodiments further include a hybrid probe having a plurality of individually selectable optical emitters and a first plurality of individually selectable electrodes and at least one other electrode, wherein the optical-stimulation signal is propagated from one of the plurality of optical emitters and the electrical-stimulation signal is applied between a one or more of the first plurality of individually selectable electrodes and one or more of the at least one other electrode. In some embodiments, the controller is configured to supply signals to the hybrid probe to selectively apply the electrical stimulation signal in a direction that is both transverse and axial to a nerve pathway.

In some embodiments, the present invention provides an apparatus that includes means as described herein and equivalents thereof for generating an electrical stimulation signal and an optical stimulation signal; and means as described herein and equivalents thereof for applying a combination of both the electrical stimulation signal and the optical stimulation signal to a living animal to trigger a nerve action potential (NAP) in vivo. In some embodiments, of the apparatus, the applied optical stimulation signal is of a nature such that if applied alone the optical signal has a low probability to trigger a NAP, the probability being no more than 25%. In some embodiments, of the apparatus, wherein the applied electrical stimulation signal is of a nature such that if applied alone the electrical signal has a low probability to trigger a NAP, the probability being no more than 25%. In some embodiments, of the apparatus, the applied electrical stimulation signal is of a nature such that if applied alone the electrical signal has a low probability to trigger a NAP, the probability being no more than 25%. In some embodiments, the means for applying the combination of both the electrical stimulation signal and the optical stimulation signal includes a plurality of electrodes configured to selectively apply an electrical signal in a direction that is substantially axial to a nerve pathway. In some embodiments, the means for applying the combination of both the electrical stimulation signal and the optical stimulation signal includes a plurality of electrodes configured to selectively apply an electrical signal in a direction that is both transverse and axial to a nerve pathway. In some embodiments, the means for applying the combination of both the electrical stimulation signal and the optical stimulation signal includes a plurality of electrodes configured to selectively apply an electrical signal in a direction that is substantially transverse to a nerve pathway. In some embodiments, the electrical signal is applied from a plurality of the electrodes to a plurality of the electrodes in order to provide a substantially uniform electric field at least across the tissue that is stimulated by the optical signal that is applied concurrently with the electrical signal. In some embodiments, the applied electrical stimulation signal and the optical stimulation signal are applied to at least one tissue of the group consisting of peripheral nerves, central nervous system (CNS) neurons, spinal cord, spinal roots, cranial nerves, nerve endings, and cardiac tissues. In some embodiments, the means for applying the combination of both the electrical stimulation signal and the optical stimulation signal includes a plurality of electrodes configured to selectively apply an electrical signal in a direction that is substantially axial to a nerve pathway. In some embodiments, the means for applying the combination of both the electrical stimulation signal and the optical stimulation signal includes a plurality of electrodes configured to selectively apply an electrical signal in a direction that is both transverse and axial to a nerve pathway.

In some embodiments, the electrical portion of the hybrid probe is optimized or configured to uniformly distribute electrical energy across the optical zone of the target tissue (wherein the optical zone (region of interest) is (the laser-spot size) times (the laser-penetration depth)). This way, the entire area will stay below threshold and maintain a constant level of ‘priming’ such that the laser energy will reliably elicit a response without the need for excess energy to be applied. In some embodiments, the electrical portion of the hybrid probe deliver monopolar stimulation pulses from a single electrode located proximate the nerve to be stimulated (in some embodiments, the pulse is monophasic, i.e., unidirectional relative to a substantially constant background voltage), while in other embodiments, the electric portion of the probe delivers bipolar stimulation pulses (wherein, in some embodiments, the pulse is monophasic (as described above), while in other embodiments, the pulse is biphasic, i.e., bidirectional relative to a substantially constant background voltage) via a voltage applied between two electrodes (or electrical-contact leads) both located in the region of interest to provide current flow. In the case of two electrodes in the hybrid probe, the probe includes two selectively activated contact probes (two electrodes selected to have a voltage applied between them, these electrodes called cathode and anode) with the optical stimulus delivered to tissue between the two probes. It is thought that there is evidence that stimulation occurs at the cathode, but basically the injected waveforms can be optimized to be more-or-less uniformly distributed electric fields over the area of optical stimulation. In some embodiments, the electrodes that are not selected are not connected (i.e., high-Z or high impedance, wherein substantially no current flows in the non-selected electrodes). Again, in some embodiments, the voltage is applied between a first subset (having more than one electrode in the first subset) of the plurality of electrodes and a second subset (having more than one electrode in the first subset) of the plurality of electrodes, in order to provide a more uniform electric field across the volume (defined by the spot area and tissue-penetration depth of the laser output) of tissue being optical stimulated by the optical-stimulation signal.

In some embodiments, the electrical-and-optical-hybrid stimulations are applied to the following tissues in addition to peripheral nerves: neurons of the central nervous system, spinal cord, spinal roots, cranial nerves, nerve endings, and cardiac tissues.

In some embodiments, a plurality of optical emitters are located in both of two opposing inner surfaces of a hybrid probe, and the optical energy or power supplied by a selected optical emitter is limited in order to provide greater selectivity (i.e., a selected one of the optical emitters on one of the two surfaces is driven with an optical signal having a limited penetration depth in order to trigger responses only in the sub-portion of the nerve located closest to that surface, and alternatively a selected one of the optical emitters on the opposing-inner-side optical emitters is driven with an optical signal having a limited penetration depth in order to trigger responses only in the portion of the nerve closes to that opposing surface of the probe).

In some embodiments, the probe provides one or more arrays of closely spaced electrodes, wherein the electric stimulation signal is selectively applied from one or more of the electrodes to one or more of the other electrodes in the one or more arrays of electrodes.

In some embodiments, both the optical signal and the electrical signal are limited in power and area in order to further enhance the selectivity of the portion of the nerve that is triggered to have a NAP.

It is to be understood that the above description is intended to be illustrative, and not restrictive. Although numerous characteristics and advantages of various embodiments as described herein have been set forth in the foregoing description, together with details of the structure and function of various embodiments, many other embodiments and changes to details will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should be, therefore, determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. In the appended claims, the terms “including” and “in which” are used as the plain-English equivalents of the respective terms “comprising” and “wherein,” respectively. Moreover, the terms “first,” “second,” and “third,” etc., are used merely as labels, and are not intended to impose numerical requirements on their objects. 

1. A method comprising: generating an electrical-stimulation signal and an optical-stimulation signal; and applying a combination of both the electrical-stimulation signal and the optical-stimulation signal to a living animal to trigger a nerve action potential (NAP) in vivo, wherein the combination, when applied, has a first probability of triggering a NAP, wherein the electrical-stimulation signal is of a nature such that if the electrical-stimulation signal is applied alone, the electrical-stimulation signal has a second probability of triggering a NAP, and wherein the first probability is greater than the second probability of triggering a NAP.
 2. The method of claim 1, wherein the optical-stimulation signal is of a nature such that, if applied alone, the optical-stimulation signal has a third probability of triggering a NAP, and wherein the third probability is no more than 25%.
 3. The method of claim 2, wherein the second probability is no more than 25%.
 4. The method of claim 1, wherein the second probability is no more than 25%.
 5. The method of claim 1, further comprising: also selectively applying a visible-indication light signal that indicates a location that the optical-stimulation signal is to be applied.
 6. The method of claim 1, further comprising: using a hybrid probe having an optical fiber inserted in an electrically conductive cannula; applying the optical-stimulation signal through the optical fiber; and applying the electrical-stimulation signal through the cannula.
 7. The method of claim 6, further comprising using a second probe to obtain an electrical-response signal representative of the triggered NAP.
 8. The method of claim 6, wherein the hybrid probe further includes an electrode that is electrically separate from the cannula, the method further comprising using the electrode to obtain an electrical-response signal representative of the triggered NAP.
 9. The method of claim 6, the method further comprising using the cannula to obtain an electrical-response signal representative of the triggered NAP.
 10. The method of claim 9, wherein a signal representative of the electrical-stimulation signal is subtracted from a signal obtained using the cannula to obtain the electrical-response signal representative of the triggered NAP.
 11. The method of claim 1, further comprising: using a hybrid probe having an optical fiber that has a metallization layer applied to the optical fiber; applying the optical-stimulation signal through the optical fiber; and applying the electrical-stimulation signal through the metallization layer.
 12. The method of claim 11, further comprising obtaining an electrical-response signal representative of the triggered NAP.
 13. The method of claim 11, wherein the hybrid probe further includes an electrode that is electrically separate from the metallization layer, the method further comprising using the electrode to obtain an electrical-response signal representative of the triggered NAP.
 14. The method of claim 11, the method further comprising using the metallization layer to obtain an electrical-response signal representative of the triggered NAP.
 15. The method of claim 1, wherein the applying of the combination of both the electrical-stimulation signal and the optical-stimulation signal includes using a plurality of electrodes configured to selectively apply the electrical-stimulation signal in a direction that is both transverse and axial to a nerve pathway.
 16. The method of claim 1, wherein the optical-stimulation signal is applied simultaneously with the electrical-stimulation signal.
 17. The method of claim 1, wherein the optical-stimulation signal is applied substantially simultaneously with the electrical-stimulation signal.
 18. The method of claim 1, wherein the optical-stimulation signal is applied at least close enough in time with the electrical-stimulation signal to trigger a NAP.
 19. An apparatus comprising: an electrical-stimulation-signal source configured to selectively output an electrical-stimulation signal; an optical-stimulation-signal source configured to selectively output an optical-stimulation signal; and a controller operatively coupled to the electrical-stimulation-signal source and to the optical-stimulation-signal source and configured to apply a combination of the electrical-stimulation signal and the optical-stimulation signal to trigger a nerve action potential (NAP) in vivo, wherein the combination, when applied, has a first probability of triggering a NAP, wherein the electrical-stimulation signal is of a nature such that if the electrical-stimulation signal is applied alone, the electrical-stimulation signal has a second probability of triggering a NAP, and wherein the first probability is greater than the second probability of triggering a NAP.
 20. The apparatus of claim 19, wherein the optical-stimulation signal is of a nature such that, if applied alone, the optical-stimulation signal has a third probability of triggering a NAP, and wherein the third probability is no more than 25%.
 21. The apparatus of claim 20, wherein the second probability is no more than 25%.
 22. The apparatus of claim 19, wherein the second probability is no more than 25%.
 23. The apparatus of claim 19, wherein the optical-stimulation signal is infrared, the apparatus further comprising a visible-indication-light-signal source configured to project visible light to indicate a location that the optical-stimulation signal is to be applied.
 24. The apparatus of claim 19, further comprising a hybrid probe having an optical fiber inserted in an electrically conductive cannula, wherein the optical-stimulation signal is applied through the optical fiber and the electrical-stimulation signal is applied through the cannula.
 25. The apparatus of claim 24, further comprising a second probe configured to obtain an electrical-response signal representative of the triggered NAP.
 26. The apparatus of claim 24, wherein the hybrid probe further includes an electrode that is electrically separate from the cannula, wherein the electrode is configured to obtain an electrical-response signal representative of the triggered NAP.
 27. The apparatus of claim 24, wherein the apparatus is configured such that the cannula is also used to obtain an electrical-response signal representative of the triggered NAP.
 28. The apparatus of claim 27, wherein the apparatus is configured to subtract a signal representative of the electrical-stimulation signal from a signal obtained using the cannula to obtain the electrical-response signal representative of the triggered NAP.
 29. The apparatus of claim 19, further comprising a hybrid probe having an optical fiber that has a metallization layer applied to the optical fiber, wherein the optical-stimulation signal is applied through the optical fiber and the electrical-stimulation signal is applied through the metallization layer.
 30. The apparatus of claim 29, further comprising a second probe configured to obtain an electrical-response signal representative of the triggered NAP.
 31. The apparatus of claim 29, wherein the hybrid probe further includes an electrode that is electrically separate from the metallization layer, and is configured to obtain an electrical-response signal representative of the triggered NAP.
 32. The apparatus of claim 29, wherein the apparatus is configured to use the metallization layer to obtain an electrical-response signal representative of the triggered NAP.
 33. The apparatus of claim 29, further comprising a hybrid probe having a plurality of individually selectable optical emitters and a first plurality of individually selectable electrodes and at least one other electrode, wherein the optical-stimulation signal is propagated from at least one of the plurality of individually selectable optical emitters and the electrical-stimulation signal is applied between a one or more of the first plurality of individually selectable electrodes and one or more of the at least one other electrode.
 34. The apparatus of claim 33, wherein the controller is configured to supply signals to the hybrid probe to selectively apply the electrical-stimulation signal in a direction that is both transverse and axial to a nerve pathway.
 35. An apparatus comprising: means for generating an electrical-stimulation signal and an optical-stimulation signal; and means for applying a combination of both the electrical-stimulation signal and the optical stimulation signal to a living animal to trigger a nerve action potential (NAP) in vivo, wherein the combination, when applied, has a first probability of triggering a NAP, wherein the electrical-stimulation signal is of a nature such that if the electrical-stimulation signal is applied alone, the electrical-stimulation signal has a second probability of triggering a NAP, and wherein the first probability is greater than the second probability of triggering a NAP.
 36. The apparatus of claim 35, wherein the applied optical optical-stimulation signal is of a nature such that, if applied alone, the optical-stimulation signal has a third probability of triggering a NAP, and wherein the third probability is no more than 25%.
 37. The apparatus of claim 36, wherein the second probability is no more than 25%.
 38. The apparatus of claim 35, wherein the second probability is no more than 25%.
 39. The apparatus of claim 35, wherein the applied electrical-stimulation signal and the optical-stimulation signal is applied to at least one tissue of the group consisting of peripheral nerves, central-nervous-system neurons, a spinal cord, spinal roots, cranial nerves, nerve endings, and cardiac tissues.
 40. The apparatus of claim 35, wherein the means for applying the combination of both the electrical-stimulation signal and the optical-stimulation signal includes a plurality of electrodes configured to selectively apply the electrical-stimulation signal in a direction that is substantially axial to a nerve pathway.
 41. The apparatus of claim 35, wherein the means for applying the combination of both the electrical-stimulation signal and the optical-stimulation signal includes a plurality of electrodes configured to selectively apply the electrical-stimulation signal in a direction that is both transverse and axial to a nerve pathway. 